CEL-SCI Corp
CVM7.340USD
+0.280+3.97%
收盘 11/05, 16:00（美东）报价延迟15分钟
39.06M总市值
亏损市盈率 TTM
关于 CEL-SCI Corp 公司
CEL-SCI Corporation 是一家处于临床后期的生物技术公司。该公司从事旨在利用免疫系统（人体的天然防御系统）改善癌症和其他疾病治疗的研究和开发。该公司专注于开发候选产品和技术，包括 Multikine 和配体表位抗原呈递系统技术 (LEAPS)。Multikine（白细胞白细胞介素注射液）是一种真正的一线癌症疗法，旨在帮助免疫系统在免疫系统仍然相对完整并因此被认为能够更好地攻击肿瘤时瞄准肿瘤。LEAPS 旨在刺激人体免疫系统更有效地对抗细菌、病毒和寄生虫感染以及自身免疫性疾病、过敏、移植排斥和癌症，而这些是人体免疫系统无法自行完成的。LEAPS 候选产品包括 CEL-2000、CEL-4000 和 DerG-PG275(Cit)（又名 CEL-5000）。
CEL-SCI Corp简介
公司代码CVM
公司名称CEL-SCI Corp
上市日期Dec 08, 1983
CEOMr. Geert R. Kersten, Esq.
员工数量- -
证券类型Ordinary Share
年结日Dec 08
公司地址Suite 802
城市VIENNA
上市交易所NYSE American Consolidated
国家United States of America
邮编22182
电话17035069460
网址https://cel-sci.com/
公司代码CVM
上市日期Dec 08, 1983
CEOMr. Geert R. Kersten, Esq.
CEL-SCI Corp公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Geert R. Kersten, Esq.
Mr. Geert R. Kersten, Esq.
Chief Executive Officer, Chief Financial Officer, Treasurer, Director
Chief Executive Officer, Chief Financial Officer, Treasurer, Director
73.41K
+0.78%
Ms. Patricia B. Prichep
Ms. Patricia B. Prichep
Co-Chief Financial Officer, Chief Operating Officer, Corporate Secretary
Co-Chief Financial Officer, Chief Operating Officer, Corporate Secretary
11.21K
+4.34%
Dr. Eyal Talor, Ph.D.
Dr. Eyal Talor, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
5.81K
+4.69%
Mr. Robert Eugene (Bob) Watson
Mr. Robert Eugene (Bob) Watson
Independent Chairman of the Board
Independent Chairman of the Board
3.73K
+358.60%
Mr. Bruno Jean-Marie Baillavoine
Mr. Bruno Jean-Marie Baillavoine
Independent Director
Independent Director
199.00
--
Mr. John Cipriano
Mr. John Cipriano
Senior Vice President - Regulatory Affairs
Senior Vice President - Regulatory Affairs
--
--
Mr. Mario Gobbo, Ph.D.
Mr. Mario Gobbo, Ph.D.
Independent Director
Independent Director
--
--
Dr. Daniel H. Zimmerman, Ph.D.
Dr. Daniel H. Zimmerman, Ph.D.
Senior Vice President - Research, Cellular Immunology
Senior Vice President - Research, Cellular Immunology
--
--
名称
名称/职务
职务
持股
持股变动
Mr. Geert R. Kersten, Esq.
Mr. Geert R. Kersten, Esq.
Chief Executive Officer, Chief Financial Officer, Treasurer, Director
Chief Executive Officer, Chief Financial Officer, Treasurer, Director
73.41K
+0.78%
Ms. Patricia B. Prichep
Ms. Patricia B. Prichep
Co-Chief Financial Officer, Chief Operating Officer, Corporate Secretary
Co-Chief Financial Officer, Chief Operating Officer, Corporate Secretary
11.21K
+4.34%
Dr. Eyal Talor, Ph.D.
Dr. Eyal Talor, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
5.81K
+4.69%
Mr. Robert Eugene (Bob) Watson
Mr. Robert Eugene (Bob) Watson
Independent Chairman of the Board
Independent Chairman of the Board
3.73K
+358.60%
Mr. Bruno Jean-Marie Baillavoine
Mr. Bruno Jean-Marie Baillavoine
Independent Director
Independent Director
199.00
--
Mr. John Cipriano
Mr. John Cipriano
Senior Vice President - Regulatory Affairs
Senior Vice President - Regulatory Affairs
--
--
收入明细
暂无数据
暂无数据
业务
地区
暂无数据
股东统计
更新时间: 10月23日 周四
更新时间: 10月23日 周四
持股股东
股东类型
持股股东
持股股东
占比
Lincoln Alternative Strategies LLC
6.94%
The Vanguard Group, Inc.
2.29%
Commonwealth Financial Network
2.19%
BlackRock Institutional Trust Company, N.A.
1.43%
Kersten (Geert R)
0.92%
其他
86.23%
持股股东
持股股东
占比
Lincoln Alternative Strategies LLC
6.94%
The Vanguard Group, Inc.
2.29%
Commonwealth Financial Network
2.19%
BlackRock Institutional Trust Company, N.A.
1.43%
Kersten (Geert R)
0.92%
其他
86.23%
股东类型
持股股东
占比
Corporation
6.94%
Investment Advisor
6.69%
Individual Investor
1.26%
Investment Advisor/Hedge Fund
1.14%
Research Firm
0.54%
其他
83.43%
机构持股
更新时间: 10月1日 周三
更新时间: 10月1日 周三
报告期
机构数
持股数
持股占比
持股变动
2025Q3
122
669.31K
8.37%
+310.99K
2025Q2
130
280.62K
4.34%
-122.18K
2025Q1
141
362.72K
6.33%
+7.45K
2024Q4
154
8.90M
11.54%
-654.04K
2024Q3
159
7.92M
12.84%
-1.82M
2024Q2
170
8.27M
15.20%
-2.00M
2024Q1
223
9.54M
17.62%
-953.00K
2023Q4
231
8.54M
17.00%
-1.14M
2023Q3
241
7.38M
15.57%
-2.53M
2023Q2
252
7.44M
15.71%
-2.96M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Lincoln Alternative Strategies LLC
555.00K
6.94%
+555.00K
--
Aug 27, 2025
The Vanguard Group, Inc.
183.21K
2.29%
+104.78K
+133.58%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
114.25K
1.43%
+88.15K
+337.80%
Jun 30, 2025
Kersten (Geert R)
73.41K
0.92%
+570.00
+0.78%
Sep 30, 2025
MAI Capital Management, LLC
64.93K
0.81%
+47.38K
+270.01%
Jun 30, 2025
BofA Global Research (US)
40.98K
0.51%
+40.92K
+68201.67%
Jun 30, 2025
UBS Financial Services, Inc.
29.82K
0.37%
+26.88K
+914.18%
Jun 30, 2025
Geode Capital Management, L.L.C.
25.92K
0.32%
+821.00
+3.27%
Jun 30, 2025
Osaic Holdings, Inc.
15.53K
0.19%
+5.89K
+61.17%
Jun 30, 2025
查看更多
持股ETF
更新时间: 18 分钟前
更新时间: 18 分钟前
机构名称
占比
iShares Micro-Cap ETF
0%
iShares Micro-Cap ETF
占比0%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
